In the past week, the Enzolytics Inc (OTCMKTS:ENZC) stock has suffered from a strong selloff and it continued on Monday as the stock ended the day with a decline of 6%. That took the cumulative decline in the stock over the course of the past week to as much as 13%.
Trading Data
On Monday, ENZC stock moved down 6.12% to $0.0690 with 12.77 million shares, compared to its average volume of 7.53 million shares. The stock moved within a range of $0.0650 – 0.0740 after opening trade at $0.0735.
Recent News
While it is true that the stock fell considerably in recent days, it may still be a good time for investors to take a look at the developments with regards to Enzolytics from Monday. The company announced that it introduced retail buyers to its Enzolytics IPF Immune product, which functions as an immune moderator. The product had actually debuted at the Weight Management, Nutrition, and Vitamin Program hosted from ECRM.
It was a major development for the company despite the fact that the Enzolytics stock suffered from a selloff. The company was given the opportunity by ECRM to showcase the product to both small and large retailers. Considering the fact that the company could end up with a significant addressable market if the presentations proved to be successful, it could be a good move to consider keeping the Enzolytics stock in your watch lists.
Technical Data
ENZC stock is trading below the 20-Day and 50-Day Moving averages of $0.0783 and $0.0843 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.1240.
